Evidence-Based Drug Policy Act of 2025

# Evidence-Based Drug Policy Act of 2025 (HR 3082) Summary **What the Bill Would Do** The Evidence-Based Drug Policy Act of 2025 would direct federal drug policy to be based on scientific research and evidence rather than tradition or ideology. While the bill's specific provisions aren't detailed in the available information, legislation with this title typically aims to reshape how federal agencies approach drug-related issues—including prevention, treatment, law enforcement, and harm reduction—by requiring decisions to be grounded in what research shows actually works. **Who It Affects** This bill would impact federal agencies responsible for drug policy (like the DEA and HHS), people struggling with substance use disorders, law enforcement, public health officials, and potentially communities affected by current drug enforcement practices.

The changes would likely influence how federal funding is allocated and what programs receive priority. **Current Status** The bill was introduced in the 119th Congress by Representative Dina Titus (D-NV) and is currently in committee, meaning it hasn't yet been debated or voted on by the full House. At this stage, the bill remains under review and has not advanced further in the legislative process.